Tranexamic acid cuts post-hepatectomy liver failure risk threefold
A new international study reveals that tranexamic acid significantly reduces the risk of liver failure following liver resection surgery. Researchers found that the medication, which prevents blood clot breakdown, could improve patient outcomes for those undergoing liver cancer treatment.
Why it matters
This discovery offers a low-cost, accessible solution to a major surgical complication, potentially saving lives and improving recovery rates for liver disease patients.
A widely available and inexpensive medication could significantly reduce the risk of one of the most serious complications following liver surgery, according to new international research.
The article reports on medical research findings in a straightforward, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in